Animal models of human breast carcinoma: Canine and feline neoplasms

Clinical and Translational Oncology

Volumn 2, Issue 6, 2000, Pages 274-281

  De Las Mulas, Juana Martín ^a   Reymundo, Carlos ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Animal models; Breast carcinoma; Canine; Feline

Indexed keywords

EID: 84873437707     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Hampe JF, Misdorp W. Tumours and dysplasias of the mammary gland. In: Beveridge WIB, Sobin LH, eds. International histological classification of tumours of domestic animals. Ginebra: World Health Organization, 1974; 111-134.
2. Madewell BR, Theilen GH. Tumors of the mammary gland. In: Theilen GH, Madewell BR, eds. Veterinary cancer medicine. Philadelphia: Lea & Febiger, 1987; 327-344.
3. Moulton JE. Tumors of the mammary gland. In: Moulton JE, ed. Tumors of domestic animals. Berkeley: University of California Press Ltd., 1990; 518-552.
4. Withrow SJ. Why worry about cancer in pet animals? In: Withrow SJ, MacEwen BR, eds. Small animal clinical oncology. Philadelphia: WB Saunders Co., 1996; 1-3.
5. Bronson RT. Variation in age and death of dogs of different sexes and breeds. Am J Vet Res 1982; 43: 2.057- 2.059.
6. Schneider R. Epidemiologic studies of cancer in man and animals sharing the same environment. Third Quadrennial Conference of Cancer Epidemiology, 1976; 1.377- 1.387.
7. Pierrepoint CG. Possible benefits to veterinary medicine of considering the dog as a model for human cancer. J Small Anim Pract 1985; 2: 43-47.
8. Weijer K, Hampe JF, Misdorp W. Mammary carcinoma in the cat 1. Arch Quirurg Neerland 1973; 25: 413-419.
9. Dorn CR, Taylor DON, Schneider R, Hibbard HH, Klauber MR. Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. J Natl Cancer Inst 1968; 40: 307-318.
10. - 10. Schneider R. Comparison of age, sex and incidence ratesin human and canine breast cancer. Cancer 1970; 26: 419-426.
11. MacEwen EG, Withrow SJ. Tumors of the mammary gland. In: Withrow SJ, MacEwen BR, eds. Small animal clinical oncology. Philadelphia: WB Saunders Company, 1996; 356-372.
12. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics: 2000. CA Cancer J Clin 2000; 50: 7-33.
13. Rosai J. Ackerman 's surgical pathology (8 th ed). St. Louis : Mosby, 1996; 2: 1.565-1.660.
14. Armstrong K, Eisen A, Weber B. Assessing the risk of breast cancer. N Engl J Med 2000; 342: 564-571.
15. Bostock DE. Canine and feline mammary neoplasms. Br Vet J 1986; 142: 506-515.
16. Robbins SL, Cotran RS, Kumar V, Collins T. Pathologic basis of disease. Philadelphia: WB Saunders Co, 1999; 433-452.
17. Hortobagyi GN. Treatment of breast cancer. N Engl J Med 1998; 339: 974-984.
18. Misdorp W. Progestogens and mammary tumors in dogs and cats. Acta Endocrinol (KbH) 1991; 125 (Supl 1): 27-31 .
19. Hayden DW, Barnes DM, Johnson KH. Morphologic changes in the mammary gland of megestrol acetatetreated and untreated cats: a retrospective study. Vet Pathol 1989; 26: 104-113.
20. Rutteman GR. Contraceptive steroids and the mammary gland: is there a hazard? Breast Cancer Res Treat 1992; 23: 29-41.
21. White E, Malone KE, Weiss NS, Daling JR. Breast cancer among young US women in relation to oral contraceptive use. J Natl Cancer Inst 1994; 86: 505-514.
22. Clarke CL, Sutherland RL. Progestin regulation of cellular proliferation. Endocrine Reviews 1990; 11: 266-301.
23. Mol JA, van Garderen E, Selman PJ, Wolfswinkel J, Rijnberk A, Rutteman GR. Growth hormone mRNA in mammary gland tumours of dogs and cats. J Clin Invest 1995; 95: 2.028-2.034.
24. Van Garderen E, de Wit M, Voorhout WF, Rutteman GR, Mol JA, Nederbragt H, Misdorp W. Expression of growth hormone in canine mammary tissue and canine mammary tumors: evidence for a potential autocrine/paracrine stimulatory loop. Am J Pathol 1997; 150: 1.037- 1.047.
25. Mol JA, Henzen-Logmans SC, Hageman P, Misdorp W, Blankenstein MA, Rijnberk A. Expression of the gene encoding growth hormone in the human mammary gland. J Clin Endocrinol Metab 1995; 80: 3.094-3.096.
26. Fitzgibbons PL, Henson DE, Hutter RVP. Benign breast changes and the risk of subsequent breast cancer, an update of the 1985 consensus statement. Arch Pathol Lab Med 1998; 122: 1.053-1.055.
27. Grupo EPIC en España. El consumo de grasas y el cáncer de mama: una asociación controvertida. Med Clín (Barc) 1997; 108: 68-74.
28. Weijer K, Head KW, Misdorp W, Hampe JF. Feline malignant mammary tumors. I. Morphology and biology: some comparisons with human and canine mammary carcinomas. J Natl Cancer Inst 1972; 49: 1.697- 1. 704 .
29. Frese K. Comparative pathology of mammary tumors of domestic animals. In: Frese K, ed. Pathology of neoplastic and endocrine-induced diseases of the breast. New York: Gustav Fischler Verlag, 1986; 44-61.
30. S harkey FE, Allred DC, Valente PT. Breast. In: Damjanov I, Linder J, eds. Anderson's pathology (10 th ed). St Louis: Mosby, 1996; 2: 2.354-2.385.
31. Scarf RW, Torloni H. Histological typing of breast tumors. In: International classification of tumors. Geneva : World Health Organization, 1968; 2: 13-20.
32. Flinner RL, Hammond EH. The myoepithelial cell in lesions of the breast: a review. Pathol Ann 1993; 28 (2): 145-169.
33. Page DL, Jensen RA, Simpson JF. Premalignant and malignant disease of the breast: the roles of the pathologist. Mod Pathol 1998; 11: 120-128.
34. Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Modern Pathol 1998; 11: 155-168.
35. Weijer K, Hart AAM. Prognostic factors in feline mammary carcinoma. J Natl Cancer Inst 1983; 70: 709-716.
36. MacEwen EG, Hayes AA, Harvey HJ, Patnaik AK, Mooney S, Passe S. Prognostic factors for feline mammary tumors. J Am Vet Med Ass 1984; 185: 201-204.
37. Hellmen E, Bergström R, Holmberg L, Spangberg I-B, Hansson K, Lindgren A. Prognostic factors in canine mammary tumors: a multivariate study of 202 consecutive cases. Vet Pathol 1993; 30: 20-27.
38. Page DL. Prognosis and breast cancer. Recognition of lethal and favorable prognostic types. Am J Surg Pathol 1991; 15: 334-349.
39. Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957; 11: 359-377.
40. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from alarge study with long-term follow-up. Histopathology 1991; 19: 403-410.
41. Gilbertson SR, Kurzman ID, Zachrau RE, Hurvitz AI, Black MM. Canine mammary epithelial neoplasms: biologic implications of morphologic characteristics assessed in 232 dogs. Vet Pathol 1983; 20: 127-142.
42. Lagadic M, Estrada M. Tumeurs mammaires de la chienn e : critères du prognostic histologique et intérêt d'un grading. Rec Méd Vét 1990; 166: 1.035-1.042.
43. Castagnaro M, Casalone C, Bozzeta E, De Maria R, Biolatti B, Caramelli M. Tumour grading on the one-year post-surgical prognosis in feline mammary carcinomas. J Comp Pathol 1998; 119: 263-275.
44. Brooks SC, Singhakowinta A. Steroid hormones in breast cancer. In: Brooks SC, Singhakowinta A, eds. Special topics in endocrinology and metabolism. New York: Alan R Liss Inc., 1982; 29-67.
45. Pertschuk LP, Kim DS, Nayer K, Feldman JG, Eisenberg KB, Carter AC, et al. Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival. Cancer 1990; 66: 1.663-1.670.
46. Martin PM, Cotard M, Mialot JP, André F, Raynaud J-P. Animal models for hormone-dependent human breast cancer. Relationship between steroid receptor profiles in canine and feline mammary tumors and survival rate. Cancer Chemother Pharmacol 1984; 12: 13-17.
47. Nerurkar VR, Chitale AR, Jalnapurkar BV, Naik SN, Lalitha VS. Comparative pathology of canine mammary tumours. J Comp Pathol 1989; 101: 389-397.
48. Misdorp W, Weijer K. Animal model of human disease. Breast cancer: feline mammary carcinoma. Registry of comparative pathology. Armed Forces Institute of Pathology. Am J Pathol 1980; 98: 573-576.
49. Raynaud JP, Cotard M, André F, Mialot JP, Rolland PH, Martin PM. Spontaneous canine mammary tumors. A model for human endocrine therapy. J Steroid Biochem 1981; 15: 201-207.
50. Donnay I, Rauis J, Verstegen J, Ectors F. Epidemiologie et hormono-dependance des tumeurs mammaires du chien. Ann Med Vet 1989; 133: 491-503.
51. Donnay I, Rauïs J, Wouters-Ballman P, Devleeschouwer N, Leclerq G, Verstegen JP. Receptors for oestrogen, progesterone and epidermal growth factor in normal and tumorous canine mammary tissues. J Reprod Fert Suppl 1993; 47: 501-512.
52. Sartin EA, Barnes S, Kinnukan MT, Wright JC, Wolfe LG. Heterogenic properties of clonal cell lines derived from canine mammary carcinomas and sensitivity to tamoxifen and doxorubicin. Anticancer Res 1993; 13: 229-236.
53. Norval M, Else RW, Maingay J. The effect of tamoxifen on tumours induced by cells from a canine mammary carcinoma cell line in athymic nude mice. Res Vet Sci 1988; 44: 76-81.
54. Hamilton JMR, Else W, Forshaw P. Oestrogen receptors in feline mammary carcinomas. Vet Rec 1976; 99: 477-479 .
55. Johnston SD, Hayden DW, Kiang DT, Handschin B, Johnston KH. Progesterone receptors in feline mammary adenocarcinomas. Am J Vet Res 1984; 45: 379-384.
56. Sartin EA, Barnes S, Kwapien RP, Wolfe LG. Estrogen and progesterone receptor status of mammary carcinomas and correlation with clinical outcome in dogs. Am J Vet Res 1992; 53: 2.196-2.200.
57. Misdorp W, Hart AAM. Prognostic factors in canine mammary cancer. J Natl Cancer Inst 1976; 56: 779-786.
58. Misdorp W, Hart AAM. Canine mammary cancer. I. Prognosis. J Small Anim Pract 1979; 20: 385-394.
59. Mandelli G, Scanziani E, Cairoli F. «Grading» istologicodelle neoplasie mammarie dei carnivori. La Clinica Veterinaria 1987; 110: 347-358.
60. Eissa S. Tumor markers in breast neoplasms. In: Eissa S, ed. Tumor markers. London: Chapman & Hall Medical, 1998; 262-273.
61. Martín de las Mulas J, Espinosa de los Monteros A, Bautista MJ, Gómez-Villamandos JC, Morales C. Immunohistochemical distribution pattern of intermediate filament proteins and muscle actin in feline and human mammary carcinomas. J Comp Path 1994; 111: 365-381.
62. De Vico G, Maiolino P, Restucci B. Silver-stained nucleolar (Ag-NOR) cluster size in feline mammary carcinomas: lack of correlation with histological appearance, mitotic activity, tumour stage, and degree of nuclear atypia. J Comp Pathol 1995; 113: 69-73.
63. Peña LL, Nieto AI, Pérez-Alenza D, Cuesta P, Castaño M. Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables. J Vet Diagn Invest 1998; 10: 237-246.